4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000899243-21-031086
Chief Business Officer bought 6,000 shares at $8.00 ($48,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Caffo Nathan Chief Business Officer | 2021-07-29 | Purchase | +6,000 | $8.00 | $48,000 | 6,000 | D: show line 1 in the form |
| Open-market purchases · 6,000 sh · avg $8.00 · $48,000 | |||||||
Loading xslF345X03/doc4.xml…